Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
07 09 2021
Historique:
received: 09 10 2020
entrez: 7 9 2021
pubmed: 8 9 2021
medline: 14 9 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global challenge that substantially risks reversing the progress in ending human immunodeficiency virus (HIV). At the same time, it may offer the opportunity for a new era of HIV management. This viewpoint presents the impact of COVID-19 on HIV care, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) "three 90s" targets. It outlines how to enhance a patient-centered care approach, now known as the "fourth 90," by integrating face-to-face patient-physician and telemedicine encounters. It suggests a framework for prevention and treatment of multimorbidity and frailty, to achieve a good health-related quality of life, and to preserve intrinsic capacity in all people living with HIV.

Identifiants

pubmed: 34492689
pii: 6041857
doi: 10.1093/cid/ciaa1864
pmc: PMC7799249
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1222-e1227

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Giovanni Guaraldi (G)

Modena HIV Metabolic Clinic (MHMC), Department of Surgical, Medical, Dental, and Morphological Sciences, University of Modena and Reggio Emilia, Italy.

Jovana Milic (J)

Modena HIV Metabolic Clinic (MHMC), Department of Surgical, Medical, Dental, and Morphological Sciences, University of Modena and Reggio Emilia, Italy.
Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.

Esteban Martinez (E)

Infectious Diseases Unit, Hospital Clínic and University of Barcelona, Barcelona, Spain.

Adeeba Kamarulzaman (A)

Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

Cristina Mussini (C)

Modena HIV Metabolic Clinic (MHMC), Department of Surgical, Medical, Dental, and Morphological Sciences, University of Modena and Reggio Emilia, Italy.

Laura Waters (L)

Mortimer Market Centre, Central & NW London NHS Trust, London, United Kingdom.

Anton Pozniak (A)

Chelsea and Westminster Hospital NHS Foundation Trust and LSHTM, London, United Kingdom.

Patrick Mallon (P)

University College Dublin Centre for Experimental Pathogen Host Research, Dublin, Ireland.

Jürgen K Rockstroh (JK)

Department of Medicine I, Bonn University Hospital, Bonn, Germany.

Jeffrey V Lazarus (JV)

Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH